Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French Experience.
Agathe MolimardCyril GitiauxChristine BarneriasFrédérique AudicArnaud IsapofUlrike Walther-LouvierClaude CancesCaroline Espil-TarisJean-Baptiste DavionSusana Quijano-RoyCoraline GriselBrigitte ChabrolIsabelle DesguerrePublished in: Neurology (2022)
This study provides Class III evidence that for children with MG, rituximab is effective and well tolerated.